NIH Issues Subcommittee
The NIH Issues Subcommittee was established to promote best practices at NIH and review and comment on a range of issues that affect NIH-funded research. The committee has addressed topics that include the NIH reauthorization, the SBIR set-aside, and ethics regulations for NIH employees.
Subcommitte objectives:
- Incubate big-picture strategic thinking about the NIH and how it funds science
- Proactively develop FASEB positions
- Monitor and respond to proposed legislative and regulatory issues not covered by other subcommittees.
Members of the subcommittee:
- Parker Antin, Ph.D. Chair (AAA, SDB)
- John Chatham, DPhil (APS)
- Avrum Gotlieb, M.D. (ASIP)
- Janet Hall, M.D., Ph.D. (ENDO)
- Paul Kincade, Ph.D. (ASIP/AAI)
- Ellen Kraig, Ph.D. (AAI)
- Virendra Mahesh, M.D. (SSR)
- Richard Marchase, Ph.D. (AAA)
- Nicola C. Partridge, Ph.D. (ASBMB, APS, ASBMR, ENDO)
- James C. Rose, Ph.D. (ENDO)
- Peter A. Rubenstein, Ph.D. (ASBMB)
- Alan Schneyer, Ph.D. (ASBMB, SSR, ENDO)
- Elizabeth J. Shane, M.D., Ph.D. (ASBMR)
- Margaret Shupnik, Ph.D. (ASBMB, SSR, ENDO)
- Zhongjie Sun, M.D., Ph.D. (APS)
- William Talman, M.D. (APS)
- Judith Van Houten, Ph.D. (GSA)
- Tyrone Spady, Ph.D. (FASEB Staff Liaison)